All data are based on the daily closing price as of March 16, 2026
c
Chong Kun Dang Pharmaceutical
185750.KO
57.97 USD
1.10
+1.93%
Overview
Last close
57.97 usd
Market cap
763.82M usd
52 week high
85.98 usd
52 week low
48.18 usd
Target price
78.01 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.6811
Price/Book Value
1.1894
Enterprise Value
799.74M usd
EV/Revenue
0.7115
EV/EBITDA
10.7608
Key financials
Revenue TTM
1.12B usd
Gross Profit TTM
351.99M usd
EBITDA TTM
72.02M usd
Earnings per Share
N/A usd
Dividend
0.33 usd
Total assets
1.09B usd
Net debt
58.95M usd
About
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.